Rubicon Technology, Inc.  

(Public, NASDAQ:RBCN)   Watch this stock  
Find more results for RBCN
4.00
+0.05 (1.27%)
After Hours: 4.00 0.00 (0.00%)
Dec 19, 5:36PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.87 - 4.08
52 week 3.56 - 14.67
Open 3.93
Vol / Avg. 864,906.00/427,607.00
Mkt cap 102.79M
P/E     -
Div/yield     -
EPS -2.02
Shares 26.15M
Beta 1.01
Inst. own 91%
Feb 17, 2015
Q4 2014 Rubicon Technology Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 19, 2014
Rubicon Technology Inc at UBS Global Technology Conference
Nov 6, 2014
Q3 2014 Rubicon Technology Inc Earnings Call
Nov 6, 2014
Q3 2014 Rubicon Technology Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -170.64% -73.11%
Operating margin -172.62% -84.03%
EBITD margin - -52.11%
Return on average assets -26.11% -13.47%
Return on average equity -26.93% -14.41%
Employees 292 -
CDP Score - -

Address

9931 FRANKLIN AVENUE
FRANKLIN PARK, IL 60131
United States - Map
+1-847-2957000 (Phone)
+1-847-2957555 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Rubicon Technology, Inc. manufactures synthetic electronic materials for opto-electronic, semiconductor fabrication, telecommunications, and optical & laser applications. The Company employs the Kyropoulos method to grow high-density single crystal sapphire and other advanced technology materials.

Officers and directors

Don N. Aquilano Independent Chairman of the Board
Age: 47
Bio & Compensation  - Reuters
William F. Weissman President, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Mardel A. Graffy Chief Financial Officer, Secretary
Age: 54
Bio & Compensation  - Reuters
Donald R. Caldwell Independent Director
Age: 67
Bio & Compensation  - Reuters
Michael E. Mikolajczyk Independent Director
Age: 62
Bio & Compensation  - Reuters
Raymond J. Spencer Independent Director
Age: 63
Bio & Compensation  - Reuters